# Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome

> **NCT05245240** · NA · UNKNOWN · sponsor: **Faculty Hospital Kralovske Vinohrady** · enrollment: 50 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- Obesity

## Interventions

- **PROCEDURE:** Dietary and physical intervention

## Key facts

- **NCT ID:** NCT05245240
- **Lead sponsor:** Faculty Hospital Kralovske Vinohrady
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05245240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05245240, "Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05245240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*